Cannara Biotech Reports Rising Revenue, Solid Financials

Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) announced its fourth quarter and fiscal year 2021 financial results for the ending on August 31, 2021. Cannara reported total revenue of $6.5 million for the fourth fiscal quarter, an increase of $5.9 million from $0.6 million in the fourth quarter of 2020. The company also delivered a net income of $1.1 million, an increase of $5.0 million from a net loss of $3.9 million in the fourth quarter of 2020. The adjusted EBITDA amounted to $1.4 million, an increase of $2.8 million from a negative adjusted EBITDA of $1.4 million in the fourth quarter of 2020.

For the full fiscal year of 2021 Cannara reported total revenue of $17.3 million, an increase of $14.7 million while the net loss amounted to $1.5 million, a significant decrease of $11.6 million from a net loss of $13.1 million in the prior year. The operating expenses fell by $2.9 million compared to prior year and the adjusted EBITDA amounted to $1.5 million, an increase of $9.8 million from the year prior.

“Our impressive increase in revenue this quarter and incredible overall results for this year demonstrate a year of sustained growth and profitability, one which continued to drive our net income and adjusted EBITDA up,” said Zohar Krivorot, President & Chief Executive Officer of Cannara. “Our three flagship brands carved unique niches in the industry, offering handcrafted, hang-dried, slow-cured and hand-trimmed cannabis with the flower’s natural properties intact. The consumer response to these products outperformed even our expectations, as we saw a remarkable increase in both new and loyal customers embracing the dynamism of our product portfolio. We are also thrilled by the continued expansion of our Cannara family, as we increasingly rely on purpose-driven leaders whose talent for strategy shape the organization’s competencies. Over the course of the next fiscal, we are well-positioned for national growth and will continue to seek opportunities that support our mission, allocating efforts to existing and new activities.”

Looking Ahead

Cannara said it plans to optimize the additional debt financing from CIBC to finalize the redesign of several zones at the Valleyfield Facility in order to replicate the indoor cultivation environment, including growing without utilizing the sun and launching the operations at the site. The first 25,000 square foot zone was propagated with 9,600 plants in November 2021 and the next 25,000 square foot zone is planned to be propagated in January 2022. Cannara also stated that its existing cash resources of $8.2 million (as of August 31, 2021), along with the forecasted cash flows and financing that occurred subsequent to year-end, will enable it to fund its planned operating expenses for at least the next twelve months from August 31, 2021.

“Our tremendous growth was driven by strategic retail activities in Québec, combined with well-thought-out operational development investments, the cultivation and sale licenses of our two mega facilities, and the cannabis revenues generated during the second half of 2021,” said Nicholas Sosiak, Chief Financial Officer of Cannara. “The incredible performance, strong balance sheet, and increase in gross profit all underscore our long-term growth strategy and commitment to our customers, against the backdrop of strong demand for our products. As we continue to generate profitable growth and outsized returns, we will move forward from a position of financial strength and are ideally positioned to showcase continued positive Adjusted EBITDA.”

After the quarter and fiscal year ended, Cannara secured an additional bank credit amounting to $22 million increased from a previous loan of $5.4 million with Canadian Imperial Bank of Commerce, and expanded to the Ontario market. The company also launched two new hash products within the Nugz brand in Quebec retail stores; Old School Hash in a 3-gram bar and Ice Water Hash in a 1-gram temple ball.

Debra Borchardt

Debra Borchardt is the CEO, Co-Founder, and Editor-In-Chief of GMR. She has covered the cannabis industry for several years at Forbes, Seeking Alpha and TheStreet. Prior to becoming a financial journalist, Debra was a Vice President at Bear Stearns where she held a Series 7 and Registered Investment Advisor license. Debra has a Masters degree in Business Journalism from New York University.


Leave a Reply

Your email address will not be published. Required fields are marked *

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

We respect your privacy. See our privacy policy.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 9 hours

Check out our latest story from Looks likes the pandemic has sparked psychedelic drug use…

@GreenMarketRpt – 9 hours

RT : Pandemic Tripping With Psychedelics 🍄🍄 Could psychedelics really be a mental health “cure-all” during a global pandemic?…

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

We respect your privacy. See our privacy policy.